
Sign up to save your podcasts
Or


China is investing heavily in cutting-edge genetic experiments. It’s part of their quest to become a biotech superpower.
On today’s Big Take Asia Podcast, host K. Oanh Ha, Bloomberg’s Karoline Kan and Oxford University geneticist Andy Greenfield discuss China’s pharmaceutical ambitions and the loose regulatory environment that allows the animal testing industry to thrive.
Read more: China Pushes Boundaries With Animal Testing to Win Global Biotech Race
See omnystudio.com/listener for privacy information.
By Bloomberg4.8
2020 ratings
China is investing heavily in cutting-edge genetic experiments. It’s part of their quest to become a biotech superpower.
On today’s Big Take Asia Podcast, host K. Oanh Ha, Bloomberg’s Karoline Kan and Oxford University geneticist Andy Greenfield discuss China’s pharmaceutical ambitions and the loose regulatory environment that allows the animal testing industry to thrive.
Read more: China Pushes Boundaries With Animal Testing to Win Global Biotech Race
See omnystudio.com/listener for privacy information.

403 Listeners

1,180 Listeners

2,171 Listeners

1,925 Listeners

439 Listeners

355 Listeners

968 Listeners

194 Listeners

61 Listeners

1,304 Listeners

70 Listeners

30 Listeners

61 Listeners

4 Listeners

157 Listeners

58 Listeners

232 Listeners

227 Listeners

60 Listeners

75 Listeners

75 Listeners

57 Listeners

81 Listeners

390 Listeners

171 Listeners

11 Listeners

21 Listeners

12 Listeners

139 Listeners

7 Listeners

2 Listeners

74 Listeners